Two founders bought the same AI tools in the same month. One added $180K in pipeline by quarter’s end. The other had 11 browser tabs of dashboards and nothing to show for it. AI ROI for early-stage startups is real but uneven — the founders seeing 3-10x returns aren’t the ones with the biggest tooling
AI for medical imaging in the mid-market represents a $2.8B opportunity by 2028, yet most founders between $50K-$3M ARR watch helplessly as enterprise giants dominate while they struggle to find their entry point. This massive market segment encompasses specialized AI applications for radiology, pathology, and diagnostic imaging designed specifically for companies beyond startup phase but


